Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23254902)

1.

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease.

Tang W, McDonald SP, Hawley CM, Badve SV, Boudville NC, Brown FG, Clayton PA, Campbell SB, de Zoysa JR, Johnson DW.

Kidney Int. 2013 Mar;83(3):503-10. doi: 10.1038/ki.2012.375. Epub 2012 Dec 19.

PMID:
23254902
2.

The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.

Tang W, Bose B, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Campbell SB, Peh CA, Johnson DW.

Clin J Am Soc Nephrol. 2013 May;8(5):773-80. doi: 10.2215/CJN.08770812. Epub 2013 Jan 24.

3.

Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease.

Deegens JK, Artz MA, Hoitsma AJ, Wetzels JF.

Clin Nephrol. 2003 Jan;59(1):1-9.

PMID:
12572924
4.

Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.

Cui Z, Zhao J, Jia XY, Zhu SN, Zhao MH.

Am J Kidney Dis. 2011 Apr;57(4):575-82. doi: 10.1053/j.ajkd.2010.09.022. Epub 2010 Dec 18.

PMID:
21168945
5.

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.

Tang W, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Campbell SB, de Zoysa JR, Johnson DW.

Nephrol Dial Transplant. 2013 Feb;28(2):455-61. doi: 10.1093/ndt/gfs492. Epub 2012 Nov 25.

6.

End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.

Mallett A, Tang W, Clayton PA, Stevenson S, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Johnson DW.

Nephrol Dial Transplant. 2014 Dec;29(12):2277-86. doi: 10.1093/ndt/gfu254. Epub 2014 Jul 24.

PMID:
25061124
7.

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Levy JB, Turner AN, Rees AJ, Pusey CD.

Ann Intern Med. 2001 Jun 5;134(11):1033-42.

PMID:
11388816
8.

Duration of end-stage renal disease and kidney transplant outcome.

Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK.

Nephrol Dial Transplant. 2005 Jan;20(1):167-75. Epub 2004 Nov 16.

9.

[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].

Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N.

G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56. Italian.

PMID:
19927265
10.

Kidney transplant outcomes in patients with Fabry disease.

Shah T, Gill J, Malhotra N, Takemoto SK, Bunnapradist S.

Transplantation. 2009 Jan 27;87(2):280-5. doi: 10.1097/TP.0b013e318191a842.

PMID:
19155985
11.

Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis.

Moon SJ, Park HS, Kwok SK, Ju JH, Kim HY, Park SH.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1):31-9. Epub 2012 Aug 30.

PMID:
22935632
13.

End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.

Tang W, Mohandas J, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Wiggins KJ, Bannister KM, Campbell SB, Johnson DW.

BMC Nephrol. 2012 Dec 3;13:164. doi: 10.1186/1471-2369-13-164.

14.

ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.

McDonald SP, Russ GR, Kerr PG, Collins JF; Australia and New Zealand Dialysis and Transplant Registry.

Am J Kidney Dis. 2002 Dec;40(6):1122-31.

PMID:
12460029
15.

Renal allograft survival in patients with oxalosis.

Cibrik DM, Kaplan B, Arndorfer JA, Meier-Kriesche HU.

Transplantation. 2002 Sep 15;74(5):707-10.

PMID:
12352890
17.

The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival.

Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD, Baird BC, Cheung AK.

Am J Kidney Dis. 2005 Sep;46(3):537-49.

PMID:
16129217
18.

Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.

Wong CF, McCarthy M, Howse ML, Williams PS.

Ren Fail. 2007;29(6):653-9. Erratum in: Ren Fail. 2008;30(3):343.

PMID:
17763158
19.

Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada.

Rabbat CG, Thorpe KE, Russell JD, Churchill DN.

J Am Soc Nephrol. 2000 May;11(5):917-22.

20.

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations.

Badve SV, Hawley CM, McDonald SP, Mudge DW, Rosman JB, Brown FG, Johnson DW; ANZDATA Registry PD Working Committee.

Nephrol Dial Transplant. 2006 Mar;21(3):776-83. Epub 2005 Nov 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk